Category: Health

Mushroom Bioactive Compounds

Mushroom Bioactive Compounds

Mushgoom assessment of citric acid, inorganic citrate Vegan lunch ideas, and alkyl citrate esters as used in cosmetics. Bulgakov VP, Avramenko TV. E1 Enshasy, H.

Mushroom Bioactive Compounds -

Texto completo. Buscar no Google. Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: ScienceDirect Idioma: Inglês Revista: Food Bioscience Ano de publicação: Tipo de documento: Artigo. Consulta Detalhada ×. Email ×. Seu nome Seu email Enviar para.

Kashif, M. An overview of dermatological and cosmeceutical benefits of Diospyros kaki and its phytocon-stituents. Brazilian J. Li, H. Anti-inflammatory activity of polysaccharide from Pholiota nameko. Biochemistry Mosc.

Ruthes, A. Agaricus bisporus fucogalactan: structural characterization and pharmacological approaches. Silveira, M. Exopolysaccharide produced by Pleurotus sajorcaju: its chemical structure and anti-inflammatory activity. Castro, A. Anti-inflamatory, anti-angiogenenic and antioxidant activities of polysaccharide-rich extract from fungi Caripia montagnei.

Chang, C. Sulfated polysaccharides of Armillariella mellea and their anti-inflammatory activities via nf-kb suppression. Guerra Dore, C.

Antiinflammatory, antioxidant and cytotoxic actions of β-glucan-rich extract from Geastrum saccatum mushroom. Akihisa, T. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum.

Choi, S. Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW Dudhgaonkar, S. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum.

Ukawa, Y. Oral administration of the extract from Hatakeshimeji Lyophyllum decastes sing. Tokyo , , 53 3 , Wang, H. Exploring the potential of using algae in cosmetics. Potential biomedical applications of marine algae.

Milhorini, S. Fucogalactan from the giant mushroom Macrocybe titans inhibits melanoma cells migration. Han, S. Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion. Njue, A. Cytotoxic ergostane derivatives from the edible mushroom Termitomyces microcarpus lyophyllaceae.

Youn, M. yeol; Kim, Y. Potential anticancer properties of the water extract of Inontus obliquus by induction of apoptosis in melanoma BF10 cells. Harhaji, Lj. Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study. Wu, J.

Phytomedicine , , 14 1 , Fyhrquist, N. Skin Biomes. Allergy Asthma Rep. Kerdudo, A. Development of a natural ingredient - natural preservative: A case study.

Kizhedath, A. Assessment of hepatotoxicity and dermal toxicity of butyl paraben and methyl paraben using HepG2 and HDFn in vitro models.

In Vitro , , 55 , Teodoro, G. Potential use of phenolic acids as anti-Candida agents: a review. Martins, N. Activity of phenolic compounds from plant origin against Candida species.

Alam, N. Consequence of the antioxidant activities and tyrosinase inhibitory effects of various extracts from the fruiting bodies of Pleurotus ferulae. Saudi J. Nuhu, A. Evaluation of the antioxidant and antityrosinase activities of three extracts from Pleurotus nebrodensis fruiting bodies.

Hapsari, R. Plants , , 2 , Development of mushroom-based cosmeceutical formulations with anti-inflammatory, anti-tyrosinase, antioxidant, and antibacterial properties. Molecules , , 21 10 , Hu, S. Tyrosinase inhibitory activity of total triterpenes and poricoic acid a isolated from Poria cocos.

Yan, Z. Inhibitory and acceleratory effects of Inonotus obliquus on tyrosinase activity and melanin formation in b16 melanoma cells. J evid based complement. Altern Med , , , Satooka, H. Effects of matsutake mushroom scent compounds on tyrosinase and murine BF10 melanoma cells.

Miyake, M. Inhibitory effects of 2-amino-3H-phenoxazinone on the melanogenesis of murine B16 melanoma cell line. An, S. p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB.

Chaiprasongsuk, A. Photoprotection by dietary phenolics against melanogenesis induced by UVA through Nrf2-dependent antioxidant responses. Redox Biol. Seo, Y. Effects of p-coumaric acid on erythema and pigmentation of human skin exposed to ultraviolet radiation.

Thangboonjit, W. Comparative evaluation of antityrosinase and antioxidant activities of dietary phenolics and their activities in melanoma cells exposed to UVA. Siriraj Med. Effect of chlorogenic acid on melanogenesis of B16 melanoma cells.

Molecules , , 19 9 , Ullah, S. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells. Lin, Y. Effects of nicotinic acid derivatives on tyrosinase inhibitory and antioxidant activities.

Otte, N. Nicotinamide - biologic actions of an emerging cosmetic ingredient. Chanioti, S. Extraction of phenolic compounds from olive pomace by using natural deep eutectic solvents and innovative extraction techniques.

Food Sci. Santos, A. Leaves and decoction of Juglans regia L. Optimization of microwave-assisted extraction of ergosterol from Agaricus bisporus L. by-products using response surface methodology. Food Bioprod. Albuquerque, B. Catechin-based extract optimization obtained from Arbutus unedo L.

Pasquel Reátegui, J. Extraction of antioxidant compounds from blackberry rubus sp. bagasse using supercritical CO2 assisted by ultrasound. Fluids , , 94 , Azmir, J. Techniques for extraction of bioactive compounds from plant materials: a review. Food Eng. Oludemi, T. Extraction of triterpenoids and phenolic com-pounds from Ganoderma lucidum: optimization study using the response surface methodology.

Pinela, J. Microwave-assisted extrac-tion of phenolic acids and flavonoids and production of antioxidant ingredients from tomato: a nutraceutical-oriented optimization study. Vieira, V.

Optimization and comparison of maceration and microwave extraction systems for the production of phenolic compounds from Juglans regia L.

for the valorization of walnut leaves. Jiménez, L. Optimization and comparison of heat and ultra-sound assisted extraction techniques to obtain anthocyanin compounds from Arbutus unedo L. Newburger, A. Cosmeceuticals: myths and misconceptions.

Lintner, K. Cosmeceuticals and active ingredients. Pauwels, M. Vinardell, M. Cosmetics , , 4 , Baumann, L. Inside cosmeceutical marketing claims. Dermatology , , De Souza, J.

Fitos , , 9 , Mushroom-based cosmeceutical ingredients: microencapsulation and in vitro release profile. Massounga Bora, A. Application of microencapsulation for the safe delivery of green tea polyphenols in food systems: review and recent advances.

Aguiar, J. Microencapsulation of natural antioxidants for food application - the specific case of coffee antioxidants - a review. Dias, M. Microencapsulation of bioactives for food applications.

Vincekovi, M. innovative technologies for encapsulation of mediterranean plants extracts. Li, Y. Effect of different encapsulating agent combinations on physicochemical properties and stability of microcapsules loaded with phenolics of plum Prunus salicina lindl.

Motilva, M. Human bioavailability and metabolism of phenolic compounds from red wine enriched with free or nano-encapsulated phenolic extract.

Foods , , 25 , Uchida, T. Permeation of topically applied caf-feine from a food by-product in cosmetic formulations: Is nanoscale in vitro approach an option? Gerstel, D. Comparison of protocols for measuring cosmetic ingredient distribution in human and pig skin.

In Vitro , , 34 , Diembeck, W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association.

Barbero, A. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. In Vitro , , 23 1 , Praça, F. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models.

Haq, A. Strat-M® synthetic membrane: Permeability comparison to human cadaver skin. Evaluation of a silicone membrane as an alternative to human skin for determining skin permeation parameters of chemical compounds. Tokyo , , 64 9 , c ] [PMID: ]. Flaten, G. In vitro skin models as a tool in optimization of drug formulation.

Žilius, M. Release of propolis phenolic acids from semisolid formulations and their penetration into the human skin in vitro. evidence-based complement. Zhang, L. A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety.

Wang, S. Synergistic, additive, and antagonistic effects of food mixtures on total antioxidant capacities. Phan, M. Interactions between phytochemicals from fruits and vegetables: Effects on bioac-tivities and bioavailability.

Han, R. Panya, A. Interactions between α-tocopherol and rosmarinic acid and its alkyl esters in emulsions: synergistic, additive, or antagonistic effect? Pinelo, M. Interaction among phenols in food fortification: negative synergism on antioxidant capacity.

Freeman, B. Synergistic and antagonistic interactions of phenolic compounds found in navel oranges. Kim, S. Submerged Production and Characterization of Grifola Frondosa Polysaccharides - A New Application to Cosmeceuticals.

Food Technol. Shen, T. Tremella fuciformis polysaccharide suppresses hydrogen peroxide-triggered injury of human skin fibroblasts via upregulation of SIRT1.

Extract of the mycelium of T. matsutake inhibits elastase activity and TPA-induced MMP-1 expression in human fibroblasts. Dietary compound ellagic acid alleviates skin wrinkle and inflam-mation induced by UV-B irradiation. Zi, Y. Antioxidant action and protective and reparative effects of lentinan on oxidative damage in HaCaT cells.

Seok, J. p-Coumaric acid attenuates uvb-induced release of stratifin from keratinocytes and indirectly regulates matrix metalloproteinase 1 release from fibroblasts.

Korean J. Kohno, K. Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazinone. Gunawardena, D. Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages.

Agrocybe chaxingu polysaccharide prevent inflammation through the inhibition of COX-2 and NO production. BMB Rep. Fucoman-nogalactan and glucan from mushroom Amanita muscaria: structure and inflammatory pain inhibition.

Quang, D. Grifolin derivatives from Albatrellus caeruleoporus, new inhibitors of nitric oxide production in RAW Deng, J. Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from Antrodia camphorata on the inflammatory mediator expression in mice.

Hsieh, Y. An-trocamphin A, an anti-inflammatory principal from the fruiting body of Taiwanofungus camphoratus, and its mechanisms. Huang, G. Analgesic effects and the mechanisms of anti-inflammation of ergostatrien-3β-ol from Antrodia camphorata submerged whole broth in mice.

Lee, C-L. First total synthesis of antrocamphin A and its analogs as anti-inflammatory and anti-platelet aggregation agents. Lin, M. Immunosuppressive effect of zhankuic acid C from Taiwanofungus camphoratus on dendritic cell activation and the contact hypersensitivity response.

Liao, Y-R. An efficient total synthesis of a potent anti-inflammatory agent, benzo-camphorin F, and its anti-inflammatory activity. Chien, S. Anti-inflammatory activities of new succinic and maleic deriva-tives from the fruiting body of Antrodia camphorata.

Wu, M-D. Maleimide and maleic anhydride de-rivatives from the mycelia of Antrodia cinnamomea and their nitric oxide inhibitory activities in macrophages. Wu, M. Inhibitory effects of maleimide derivatives from the mycelia of the fungus Antrodia cinnamomea BCRC on nitric oxide production in lipopolysaccharide LPS -activated RAW Queiroz, L.

Moura, Mde. Glucans from the Caripia montagnei mushroom present anti-inflammatory activity. PNPS-1 also improved pathological changes in the coronary arteries of hyperlipidemic rats.

These results suggest that PNPS-1 significantly reduces the development of hyperlipidemia and could be used as a potential therapeutic agent for CVD [ 35 ]. Anti-atherogenic and antiatherosclerotic effects of different mushrooms belonging to the genera: Armillaria, Agaricus, Boletus, Collybia, Cortinfrius, Coriolus, Flammulina, Hirneola, Lentinus, Ganoderrna, Lyophyllurn, Sarcodon, Pleurotus, Tricholoma, and Trenella were detected in human intima aortic culture.

The results showed that anti-atherosclerotic, anti-atherogenic, and hypolipidemic effects of certain species of mushrooms allow us to speculate that these edible fungi are beneficial dietary supplements that might be utilized in prophylactics and to a limited extent, in atherosclerotic medicines.

Furthermore, the extraction and purification of the active substance from these mushrooms may result in the development of a strong anti-atherosclerotic medicine [ 36 ].

Among the Pleurotus species, P. ostreatus was the best candidate for the prevention and treatment of atherosclerosis because it has been shown to contain a large number of antiatherosclerotic agents such as ergothionein, lovastatin, and chrysin [ 37 ]. Mushroom active compounds against cardiovascular diseases CVDs.

Mushrooms are fungi that either grow above or below the ground. These are the macro fungi that can be easily seen with the naked eye.

Mushrooms have been used since ancient times by the people of India and China or their medicinal properties. Nowadays many countries are consuming mushrooms for not only their unique flavor but also for their culinary effects.

As many studies have revealed that mushrooms are rich sources of: proteins, carbohydrates, vitamins B1, B2, B12, C, D, and E and minerals like Mn, Mg, Se, Ca, Na, Cu, K, and Fe [ 38 ]. These nutritional factors in mushrooms have made it very efficient to fight diabetes. In vitro and in vivo studies have shown that the extract of mushrooms can reduce the expression of proinflammatory cytokines, induced by lipopolysaccharides which further improved the glucose uptake in skeletal muscle cell lines [ 39 ].

One of the most active biomolecules of mushrooms is β-glucans, a polysaccharide that can protect the pancreatic tissue from damage and restore the function of b-cells which helps to lower the blood glucose levels [ 40 ].

The low energy, lack of cholesterol and fats, less carbohydrates, and high minerals, proteins and vitamins made mushrooms an ideal food for diabetic patients. The consumption of mushrooms for a few days only can help to manage the low-density lipoproteins, total cholesterol, high-density lipoprotein, triglycerides levels in serum [ 10 ].

Besides bioactive molecules, mushrooms are very good in antioxidants activity and are also a good source of dietary fibers and water. Some of the most culinary properties containing mushrooms are Agaricus bisporus, Agaricus subrufescens, Cordyceps millitaris, Cordyceps sinensis, Grifola frondosa, Ganoderma lucidum, Phellinus linteus, Pleurotus flabellatus, Pleurotus citrinopileatus, Pleurotus ostreatus, Poria cocos [ 10 , 41 ].

Extracts of Ganoderma lucidum contain: polysaccharides, triterpenoids, proteoglycans, and proteins which have been shown to reduce blood glucose levels. The proteoglycans of G. lucidum inhibit the tyrosine phosphatase 1B protein in diabetic patients. lucidum has proven to be very effective in controlling diabetes.

Moreover, the triterpenoid from G. lucidum inhibits the aldose reductase and a-glucosidase enzymes which are responsible for the elevation of postprandial glucose levels [ 42 ].

Polysaccharides from G. atrum PSG-1 increase insulin sensitivity and lower the serum lipid by increasing and decreasing the expression levels of Bcl-2 and Bax, respectively in pancreatic cells [ 43 ].

Heteropolysaccharides are one of the bioactive molecules of Pleurotus ostreatus that control diabetes by activating the Glycogen synthase kinase 3 GSK3 by phosphorylation and facilitating the translocation of glucose transporter type 4 GLUT4 in streptozotocininduced diabetic rats [ 44 ].

Lentinula edodes promote the growth of gut microbiota, which play a very important role to balance the energy in diabetic patients. Another mushroom, Hirsutellas inensis shows antidiabetic, antiobesogenic effects in high-fat-diet feed-mice by modification of the components of gut microbiota.

The polysaccharides and fibers of mushrooms act as prebiotics that helps in the treatment of diabetic patients [ 45 ]. Recently, researchers have found the potential effects of mushrooms in diabetic nephropathy conditions.

Polysaccharides from Auricularia auricula are very helpful in promoting the oxidation of glucose. This polysaccharide protects against diabetic nephropathy by the regulation of creatinine, inflammatory factors, blood urea nitrogen, and urine protein. Polysaccharides isolated from Flammulina velutipes provided protection against reactive oxygen species ROS and reduced the level of malondialdehyde MDA in the kidney.

The studies have also revealed that the proteoglycans from Ganoderma lucidum can restore kidney function by providing antioxidant activity [ 46 ].

According to a study conducted by Chou, Kan, Chang, Peng, Wang, Yu, Cheng, Jhang, Liu and Chuu [ 47 ], low molecular weight polysaccharide of Inonotus obiquus LIOP significantly reduces the expression of NF-jB and Transforming growth factor-beta TGF-b in a dose-dependent manner [ 48 ].

They find that LIOP treatment can improve glucolipotoxicity induced renal fibrosis in diabetic nephropathy mice. Hypsizigusm armoreus have been used to examine its protective effect on the liver, kidney, and pancreas. The spent mushroom compost polysaccharide SCP , its enzymatic lysates ESCP , and acid-based hydrolyzed SCP ASCP were tested in streptozotocin-induced mice and found that it increased the: catalase, superoxide dismutase, and glutathione peroxidase activity whereas, it reduced the lipid peroxide and malonaldehyde levels [ 49 ].

a-glucosidase inhibiting polysaccharide ePS-F with triterpenoids had been purified from Coriolus versicolor. Another bioactive molecule, MT-a-glucan polysaccharide from Grifola frondosa increases the expression of Interleukin-2 IL-2 and prevents the injury of b-cells [ 50 ].

Submerged cultured mycelium of Agaricus brasiliensis and G. lucidum has shown a protective effect on red blood cells RBCs in Streptozotocin STZ -induced diabetic rats [ 51 ]. Reproductive system diseases are responsible for several types of cancers like: prostate cancer, breast cancer, ovarian cancer, cervical cancer, uterine cancer, colorectal cancer etc.

The bioactive compounds present in the mushroom are playing an important role in the treatment of reproductive disease-associated cancers. There are several medicinal mushrooms like Ganoderma lucidum , Trametes versicolor, Inonotus obliquus, Fomitopsis officinalis , etc.

which are frequently used in the treatment of cancer. Prostate cancer is the third leading cause of cancer deaths in men worldwide and the utmost common male malignancy in several western countries.

The incidence rate of prostate cancer is highest in the United States, lower in European countries and lowest in Asia [ 52 ]. The common risk factor related to prostate cancer is age, obesity, family history, environmental factors and dietary factors [ 53 ].

Retinoblastoma Rb and p53 tumor suppressor gene play a vital role in the progression of prostate cancer [ 54 ]. To combat these problems, natural compounds and fungal metabolites can be used as inhibitors for targeting cancerous cells in certain cancers [ 55 , 56 , 57 , 58 ]. Ganoderma lucidum belongs to the Ganoderma genus, oriental medicinally mushroom, which have been widely used in Asian countries for centuries to cure different diseases including cancer.

Plenty of species of this genus have antiviral, antibacterial, antifungal, anticancer, and immune-stimulating activities [ 59 ]. These activities were due to the production of various bioactive compounds present in medicinally mushrooms such as proteins [ 60 , 61 , 62 ], terpenes, sterols, and polyphenols, etc.

The dried powder of G. lucidum is used as dietary supplements and is also used as a chemotherapeutic agent for cancer therapy. It induced the apoptosis of prostate cancer PC-3 cells by lowering the expression of NF-jB-mediated Bcl-2 and Bcl-xl expression while the upregulation of the Bax protein [ 63 ].

The extracts of G. lucidum suppress the proliferation of cells and induce the G1 cell cycle in prostate cancer and breast cancer cells line [ 64 ]. Trametes versicolor, is a medicinal mushroom, belongs to the class Agaricomycetes shows anti-proliferative effects upon hepatocellular carcinoma cells HCC , prostate cancer DU and human breast cancer 4 T1 [ 42 ].

Several studies suggested that in T. versicolor β-glucan-based polysaccharopeptide fraction PSP and polysaccharide fraction PSK are present which are used as immunotherapeutic anticancer agents [ 65 ]. PSP activates cells of the immune system by enhancing the secretion of histamine, chemokines and cytokines such as interleukins IL-1b and IL-6 , TNF-a and prostaglandin E which excites dendrite and T-cell infiltration into tumor and lowers the damaging undesirable effects of chemotherapy [ 66 ].

Breast cancer is becoming one of the most common leading causes of mortality among women. The molecular subtypes of breast cancer are identified by gene expression profiles and lead to the identification of biomarkers that may ease the prognosis and treatment of cancer [ 67 ].

The molecular and pathological marker for the treatment of breast cancer is based on the presence or absence of progesterone receptors PR , estrogen receptor ER , and human epidermal growth factor receptor 2 HER2 [ 67 ].

To overcome this problem, the medicinally mushroom is widely utilized in modern integrative oncology and given to patients regularly. The clinical results suggested that T. versicolor inhibits the human triple-negative breast cancer cells MDA-MB in the in vitro culture and reduced their growth [ 68 ] and is used as a supplement in the treatment of breast cancer.

The mushroom Inonotus obliquus, often known as Chaga mushroom, belongs to the Agaricomycetes class and is widely used as traditional medicine for cancer therapy in Korea, China, Japan, and Russia [ 69 ].

Scientists illustrated that the water extracts of Chaga mushroom have shown cytotoxic and antimitotic activity on HeLa cells. The polysaccharides from I. obliquus inhibit the migration of cancer cell lines and shows anti-metastatic activities in vitro. The bioactive compounds present in the Ganoderma species are a viable alternative to fight breast cancer.

The aqueous extracts of G. lucidum, G. sinense and G. tsugae were widely used against breast cancer cells. The data illustrated that the aqueous extract of these species has anti-proliferative activities against MCF-7 cells and MDA-MB cells.

However, the aqueous extract of G. tsugae was most effective against MCF-7 cells, although the activity of other Ganoderma species is similar to MDA-MB cells.

It also established that the extract did not show any cytotoxic activity against human noncancerous epithelial cells [ 72 ]. Several results showed that G.

lucidum suppressed the proliferation of MDA-MB cells in a dose and time-dependent manner [ 64 ]. The spore powder of G. lucidum also exhibited potent cytotoxic effects in the MDA-MB, triple-negative breast cancer cell lines, and SUMcell line and overexpressing the HER2 gene in MDA-MB [ 73 ].

Some auspicious evidence illustrated that using fungal extracts can help prevent breast and gastrointestinal cancers. Some studies confirmed antiviral, antibacterial, anticancer, and anti-inflammatory activity of crude extract of F.

officinalis in different forms of cancers [ 75 ]. officinalis extract, Lanostane-type triterpenoids, was reported which showed promising anticancer activity. Scientists showed that the ethanol extracts of F. officinalis are more effective in comparison with water extract against human breast cancer MDAMB cells, colon cancer HCT , lung cancer A , mouse sarcoma S and hepatoma HepG2 cells [ 75 ].

Figure 4 shows the therapeutic activity of mushrooms and their biomolecules in the treatment of different forms of cancer.

The immune system plays a very contributing role in the progression of tumors toward cancer. Mushroom shows its therapeutic activity by targeting the components of the immune system and also modulates the apoptotic processes. Figure 4 suggests the therapeutic activity of mushrooms by modulating the different components of the immune system and also regulates the apoptotic processes in cancerous cells [ 76 , 77 , 78 ].

Antitumor mechanism of bioactive compounds in medicinal mushroom. Bioactive molecules in mushrooms also prevent the progression of different NDs. In addition, the clinical symptoms of PD were also alleviated by mushroom supplements rich in phytochemicals, minerals, and vitamins [ 79 ].

Anti-inflammatory and antioxidative activity is exhibited by dietary mushrooms containing significant quantities of carotenoids, polysaccharides, minerals, polyphenols, and vitamins [ 80 ].

The two major factors that are responsible for the progression of PD are oxidative stress and neuroinflammation. Thus, the biomolecules present in edible mushrooms offer significant neuroprotection by their anti-oxidative and anti-inflammatory activity by preventing the progressive degeneration of dopaminergic neurons [ 79 ].

One of the major factors responsible for the generation of neuroinflammation in PD is the activation of microglial cells.

Ganoderma lucidum extract GLE inhibited the activation of these microglial cells and ultimately preventing the progressive degeneration of dopaminergic neurons in PD. Tumor necrosis factoralpha TNF-a and interleukin-1b IL-1b are the examples of some important proinflammatory cytokines whose expression was downregulated by GLE in a dose-dependent manner and can be treated by natural antibiotics reported in [ 81 ].

Further progression of PD is prevented by inhibition of these proinflammatory cytokines by GLE. Thus, the treatment of PD, GLE should be utilized as an effective anti-inflammatory medication [ 82 ].

For the treatment of PD, niacin-rich food can be very beneficial and offers significant protective activity. Niacin-rich mushroom content offers potential therapeutic efficacy in the treatment of PD [ 83 ].

In the rotenone intoxicated model of PD, neuroprotective activity was shown by the Agaricus blazei extract ABE. ABE also improves rotenone-induced non-motor and motor complications in PD. Therefore, for the treatment of PD, ABE might also be utilized as a nutritional supplement [ 84 ].

Some herbal plants like Tinospora cordifolia , Withania somnifera , Mucuna pruriens Mp , and the essential oils also exhibit neuroprotective activity similar to mushrooms in toxin-induced PD mouse models [ 85 , 86 , 87 ]. In addition, bioactive components of Mp like Ursolic acid also exhibits potent antioxidative and anti-inflammatory property in toxin-induced PD model [ 88 , 89 , 90 ].

Chlorogenic acid also exhibits a similar AntiParkinsonian activity in the mouse model of PD [ 91 ]. Neuroinflammation along with oxidative stress mainly contributes to the pathogenesis of AD.

The redox status in the cell of AD is significantly impaired [ 1 ]. Mushrooms have all the essential components that restore the normal balance of the redox system in AD models and patients. Proper and accurate functioning of mitochondria is required to maintain energy homeostasis. The synthesis of vital energy equivalents is hampered by abnormal mitochondrial functioning.

In the neuroprotective network, inflammasome is an example of a very vital component. In AD, mitochondrial functioning was improved by Coriolus and Hericium. Normal redox balance was also maintained by these two nutritional mushrooms.

Thus, energy homeostasis in AD was maintained by the above-mentioned two mushrooms by their antioxidative and anti-inflammatory properties [ 92 ].

One of the best examples of both medicinal and edible mushrooms is the Hericium erinaceus HE. Both in vitro and in vivo model systems show the neuroprotective activity of HE. The aqueous extract of HE rich in a mycelium polysaccharide shows potent anti-apoptotic activity in l-glutamic acid l-Glu -induced differentiated PC12 DPC12 cell lines.

The AD mouse model induces by the combination of AlCl 3 with D-galactose. The aqueous extract of HE prevents the further progression of AD by its neuroprotective potential. Behavioral abnormalities were also improved by the aqueous extract of HE in the AD mouse model. In a dosedependent manner, HE is responsible for the enhancement of choline acetyltransferase ChAT and acetylcholine Ach in serum and hypothalamus.

To avert the pathogenesis of AD, the hypothalamus and serum level of Ach and ChAT is very vital. HE could be an efficient neuroprotective agent in AD and for some other neurodegenerative diseases [ 22 ].

For the treatment of different diseases, Coriolus versicolor CV mushroom is also widely utilized as a nutritional supplement. The oxidative stress and neuroinflammation were considerably reduced by the CV in AD.

CV also improve the quality of mitochondria and restores the normal redox balance [ 92 ]. Human wellness was effectively maintained by the bioactive molecules present in prebiotics such as legumes [ 93 , 94 , 95 ], spirulina [ 96 ], biological nanoparticles [ 93 , 97 ], mushroom [ 30 ].

Similar to PD, some herbal plants like Bacopa monnieri, Withania somnifera, Eclipta alba, Moringa oleifera and cucumber also improves cognitive function as suggested by some researchers [ 98 , 99 , , , , ].

In addition, the neuroinflammatory pathways are also significantly modulated by a variety of medicinal mushrooms in AD [ ]. Cognitive dysfunction is the very basic clinical feature of HD.

In the edible mushroom Polyozellus multiplex, Polyozellin is a very important biomolecule having significant therapeutic activity.

In the HD model, glutamate-induced mouse hippocampal neuronal HT22 cell death was significantly ameliorated by Polyozellin by apoptosis and the MAPK pathway. In HT22 cells, biochemical anomalies like lipid peroxidation and reactive oxygen species ROS were reduced by Polyozellin. Therefore, Polyozellin might be utilized for the treatment of HD patients in near future [ ].

In the animal model of multiple sclerosis MS , the disease conditions were ameliorated by Piwep, a mushroom extract from Phellinus igniarius. The dietary mushrooms and their bioactive components also improve the disease pathology in MS as with other NDs [ ].

NFjB and Nrf2 mediated neuroinflammatory pathways are mainly responsible for mitochondrial dysfunction and ultimately cause progressive neurodegeneration in all NDs. Thus, the biomolecules of mushrooms play a very potential role to reduce the pathogenesis associated with NDs.

Further studies will need to characterize more biomolecules in mushrooms and test their efficacy in several NDs. Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3. Edited by Naofumi Shiomi. Open access peer-reviewed chapter Mushroom; Chemistry, Bioactive Components, and Application Written By Ahmed M.

Saad, Mahmoud Z. Sitohy, Belal A. Omar, Mohamed T. El-Saadony and Basel Sitohy. DOWNLOAD FOR FREE Share Cite Cite this chapter There are two ways to cite this chapter:.

Choose citation style Select style Vancouver APA Harvard IEEE MLA Chicago Copy to clipboard Get citation. Choose citation style Select format Bibtex RIS Download citation.

IntechOpen Current Topics in Functional Food Edited by Naofumi Shiomi. From the Edited Volume Current Topics in Functional Food Edited by Naofumi Shiomi and Anna Savitskaya Book Details Order Print.

Chapter metrics overview Chapter Downloads View Full Metrics. Impact of this chapter. Abstract Apposite energy is required for body activity. Keywords mushroom species bioactive components anticancer antidiabetic. Ahmed M. Sitohy Department of Biochemistry, Faculty of Agriculture, Zagazig University, Egypt Belal A.

Omar Department of Biochemistry, Faculty of Agriculture, Zagazig University, Egypt Mohamed T. Introduction Mushrooms are a group of fungi with a distinctive fruiting body that can be either epigeous or hypogenous and large enough to be seen with the naked eye and picked by hand [ 1 ].

Table 1. Nutritional values of edible mushrooms and their activities. Cordyceps sinensis, Magic Milk Grifola frondosa, Inonotus obliquus, Hericium erinaceus. Table 2. Bioactive components in common mushroom. References 1. Valverde ME, Hernández-Pérez T, Paredes-López O. Edible mushrooms: Improving human health and promoting quality life.

International Journal of Microbiology. DOI: Singh M. Mushroom Biotechnology: The rise of the fallen. International Society for Optics and Photonics.

close ; } } this. getElementById iframeId ; MMushroom. max contentDiv. scrollHeight, contentDiv. offsetHeight, contentDiv.

Muhroom principal Mushroom Bioactive Compounds Busca 2 Compoundd 3. Bioacgive Pesquisa Bioactive compounds from mushrooms: An emerging bioresources Compouunds food and nutraceuticals Musheoom compounds from Bioacrive An emerging bioresources Comppunds food Holistic allergy treatment nutraceuticals.

Mushroom Bioactive Compounds, Harpreet, Kour, Divjot, Kour, Satvinder, Singh, Shaveta, Vegan lunch ideas Hashmi, Syed Azhar, Yadav, Ajar Mushroom Bioactive Compounds, Kumar, Krishan, Sharma, Yash Pal, Bioacive, Amrik Singh. Food Bioscience ; : Artigo em Inglês ScienceDirect ID: covidwho Anti cancer compounds ; Bioactive compounds ; Biodiversity ; Food industry ; Mushrooms ; Nutraceuticals ; Nutritive value.

Texto completo. Buscar no Google. Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: ScienceDirect Idioma: Inglês Revista: Food Bioscience Ano de publicação: Tipo de documento: Artigo.

Consulta Detalhada ×. Email ×. Seu nome Seu email Enviar para. Exportar ×. Formato de exportação: RIS Reference Manager, ProCite, EndNote, etc CSV Excel, etc Citação. RSS ×. Visualizar RSS Adicionar RSS na Minha BVS. Imprimir ×. Esta página Referências selecionadas 0.

: Mushroom Bioactive Compounds

Edible Mushrooms: Cultivation, Bioactive Molecules, and Health Benefits | SpringerLink Structural characteristics and bioactive properties of a novel polysaccharide from Flammulina velutipes. In addition, bioactive components of Mp like Ursolic acid also exhibits potent antioxidative and anti-inflammatory property in toxin-induced PD model [ 88 , 89 , 90 ]. This fungus is known to have potential pharmacologically active secondary metabolites which belong to small molecular weight compounds in addition to the minerals and major macromolecules, i. Kasprzycka A, Lalak-Kańczugowska J, Tys J. Yamabushitake , and its medicinal utilization.
Human Verification

Sánchez C Cultivation of Pleurotus ostreatus and other edible mushrooms. Appl Microbiol Biotechnol 85 5 — PubMed Google Scholar. Dundar A, Acy H, Yildiz A Yield performance and nutritional contents of three oyster mushroom species cultivated on wheat stalk.

Afr J Biotechnol — Pavel K Chemical composition and nutritional value of European species of wild growing mushrooms: a review. Food Chem 1 :9— Heleno SA, Barros L, Sousa MJ, Martins A, Ferreira ICFR Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity.

Mattila P, Konko K, Euvola M, Pihlava J, Astola J, Vahteristo L Contents of vitamins, mineral elements and some phenolic compound in cultivated mushrooms. J Agric Food Chem — Barros L, Cruz T, Baptista P, Estevinho LM, Ferreira IC Wild and commercial mushrooms as source of nutrients and nutraceuticals.

Food Chem Toxicol — CAS PubMed Google Scholar. J Food Compos Anal — Sánchez C Modern aspects of mushroom culture technology. Appl Microbiol Biotechnol 64 6 — Ferreira ICFR, Barros L, Abreu RMV Antioxidants in wild mushrooms.

Curr Med Chem — Pereira E, Barros L, Martins A, Ferreira ICFR Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats. Vaz JA, Heleno SA, Martins A, Almeida GM, Vasconcelos MH, Ferreira ICFR Wild mushrooms Clitocybe alexandri and Lepista inversa : in vitro antioxidant activity and growth inhibition of human tumour cell lines.

Ahlawat OP, Manikandan K, Singh M Proximate composition of different mushroom varieties and effect of UV light exposure on vitamin D content in Agaricus bisporus and Volvariella volvacea.

Mushroom Res 25 1 :1—8. Rathee S, Rathee D, Rathee D Mushrooms as therapeutic agents. Braz J Pharmacogn 22 2 — Sadler M, Saltmarsh M Functional foods: the consumer, the products and the evidence. Royal Society of Chemistry, Cambridge, UK. Longvah T, Deosthale YG Composition and nutritional studies on edible wild mushroom from Northeast India.

Maga JA Mushroom flavor. J Agric Food Chem —4. Clifford AJ, Heid MK, Peerson JM, Bills ND Bioavailability of food folates and evaluation of food matrix effects with a rat bioassay.

J Nutr — Bano Z, Rajarathnam S Pleurotus mushrooms. Part II. Chemical composition, nutritional value, post-harvest physiology, preservation, and role as human food. Crit Rev Food Sci Nutr — Mau JL, Chao GR, Wu KT Antioxidant properties of methanolic extracts from several ear mushrooms.

Ribeiroa B, Pinhoa PG, Andradea PB, Baptistab P, Valentao P Fatty acid composition of wild edible mushrooms species: a comparative study. Microchem J — Xu T, Beelman RB The bioactive compounds in medicinal mushrooms have potential protective effects against neurodegenerative diseases.

Adv Food Technol Nutr Sci Open J 1 2 — Article Google Scholar. Yip KP, Fung KP, Chang ST, Tam SC Purification and mechanism of the hypotensive action of an extract from edible mushroom Pleurotus sajor-caju. Neurosci Lett Suppl Wang HX, Liu WK, Ng TB et al The immunomodulatory and antitumor activities of lectins from the mushroom Tricholoma mongolicum.

Article CAS PubMed Google Scholar. Chang ST, Buswell JA, Chiu SW Mushroom biology and mushroom products. The Chinese University Press, Hong Kong.

Kasuga A, Aoyagi Y, Sugahara T Antioxidative activities of several mushroom extracts. J Jpn Soc Food Sci Technol — Mau JL, Lin HC, Song SF Antioxidant properties of several specialty mushrooms.

Food Res Int — Sun MT, Xiao JT, Zhang SQ, Liu YJ, Li ST Therapeutic effect of some foods on hyperlipidermia in man.

Acta Nutr Sin — Tokita F, Shibukawa N, Yasumoto T, Kaneda T Isolation and chemical structure of the plasma-cholesterol reducing substance from shiitake mushroom. Mushroom Sci — Ryong LH, Tertov VV, Vasiley AW, Tutelyan VA, Orekhov AN Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture.

Drug Dev Res — Cimerman NG Medicinal value of the genus Pleurotus Fr. Agaricales S. Cheung PCK The hypocholesterolemic effect of two edible mushrooms: Auricularia auricula tree ear and Tremella fuciformis white jelly-leaf in hypercholesterolemic rats.

Nutr Res — Kabir Y, Kimura S Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats. J Nutr Sci Vitaminol — Chen Q Antilipemic effect of polysaccharides from Auricularia auricular, Tremella fuciformis, and Tremella fuciformis spores.

Zhongguo Yaoke Daxue Xuebao — Sheng J, Chen Q Effects of polysaccharides from Auricularia auricula , Tremella fuciformis , and Tremella fuciformis spores on experimental thrombin formation. Zhongguo Yaoke Daxue Xuebae — Mizuno T Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi.

Food Rev Int — Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilara-Contreras A, Contreras-Weber CC, Flores-Sanez JL Study of the antihyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol — Ahmad N, Bansal AK, Kidwai JR Effect of PHA-B fraction of Agaricus bisporus lectin on insulin release and 45Ca2C uptake by islet of Langerhans in vitro.

Acta Diabetol — Gray AM, Flatt PR Insulin-releasing and insulin-like activity of Agaricus campestris mushroom. J Endocrinol — Windholz M The Merck index, 10th edn. Merck and Co, Rahway.

Thekkuttuparambil AA, Kainoor K Janardhanan. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr — Lucas EH, Montesano R, Pepper MS, Hafner M, Sablon E Tumor inhibitors in Boletus edulis and other holobasidiomycetes. Antibiot Chemother —4.

Lucas EH, Byerrum M, Clarke DA, Reilly HC, Stevens JA, Stock CC Production of oncostatic principles in vivo and in vitro by species of the genus Calvatia. Antibiot Annu — Reshetnikov SV, Wasser SP, Tan KK Higher basidiomycetes as a source of antitumor and immunostimulating polysaccharides review.

Lindequist U, Teuscher E, Narbe G Neue Wirkstoffe aus Basidiomyceten. Phytothérapie — Eo SK, Kim YS, Lee CK, Han SS Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum.

Yakugaku Zasshi — Mothana RAA, Jansen R, Julich WD, Lindequist U Ganomycin A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod — Bender S, Dumitrache CN, Backhaus J, Christie G, Cross RF, Lonergan GT A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal shiitake mushroom [ Lentinus edodes Berk.

singer] Agaricomycetidae. Badalyan SM Antiprotozoal activity and mitogenic effect of mycelium of culinary-medicinal shiitake mushroom Lentinus edodes Berk.

singer Agaricomycetidae. Brandt CR, Piraino F Mushroom antivirals. Recent Res Dev Antimicrob Agents Chemother — El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N Anti-HIV-1 and antiHIVprotease substances from Ganoderma lucidum.

Sano M, Yoshino K, Matsuzawa T, Ikekawa T Inhibitory effects of edible higher basidiomycetes mushroom extracts on mouse type IV allergy. Kohda H, Tokumoto W, Sakamoto K, Fujii M, Hirai Y, Yamasaki K The biologically-active constituents of Ganoderma lucidum Fr Karst-histamine release-inhibitory triterpenes.

Chem Pharm Bull — Tasaka K, Mio M, Izushi K, Akagi M, Makino T Anti-allergic constituents in the culture medium of Ganoderma lucidum. The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions — Kreisel H, Lindequist U, Horak M Distribution, ecology and immunosuppressive properties of Tricholoma populinum Basidiomycetes.

Zentralbl Mikrobiol — Ali NAA, Pilgrim H, Ludke J, Lindequist U Inhibition of chemiluminescence response of human mononuclear cells and suppression of mitogen induced proliferation of spleen lymphocytes of mice by hispolon and hispidin.

Pharmazie — Kim SH, Song YS, Kim SK, Kim BC, Lim CJ, Park EH Anti-inflammatory and related pharmacological activities of the n-BuOH subfraction of mushroom Phellinus linteus. Zhang Y, Mills G, Nair MG Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa.

Chen RY, Yu DQ Studies on the triterpenoid constituents of the spores from Ganoderma lucidum Karst. J Chin Pharm Sci — Wang MY, Liu Q, Che QM, Lin ZB Effects of total triterpenoids extract from Ganoderma lucidum Curt. Reishi mushroom on experimental liver injury models induced by carbon tetrachloride or d -galactosamine in mice.

Chang ST, Miles PG Mushrooms: cultivation, nutritional value, medicinal effect and environmental impact, 1st edn. CRC Press, Boca Raton. Badalyan SM Edible ectomycorrhizal mushrooms.

In: Zambonelli A, Bonito G eds Edible ectomycorrhizal mushrooms. Soil Biology series, vol Springer, Berlin, pp — ISBN: Guillamón S, García-Lafuente A, Lozano M et al Edible mushrooms: role in the prevention of cardiovascular diseases.

Fitoterapia 81 7 — Chu KT, Xia LX, Ng TB Pleurostrin, an antifungal peptide from the oyster mushroom.

Peptides 26 11 — Wang JB, Wang HX, Ng TB A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides 28 3 — Ngai PHK, Zhao Z, Ng TB Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea. Peptides 26 2 — Zhang Y, Mills GL, Nair MG Cyclooxygenase inhibitory and antioxidant compounds from the fruiting body of an edible mushroom, Agrocybe aegerita.

Wang J, Liu YM, Cao W et al Anti-inflammation and antioxidant effect of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats.

Metab Brain Dis 27 2 — Qian GM, Pan GF, Guo JY Anti-inflammatory and antinociceptive effects of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis. Wong JH, Ng TB, Wang H et al Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris.

Phytomedicine 18 5 — Liu QH, Wang HX, Ng TB First report of a xylose-specific lectin with potent hemagglutinating, antiproliferative and anti-mitogenic activities from a wild ascomycete mushroom.

Biochim Biophys Acta 12 — Zhang GQ, Sun J, Wang HX A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa. Acta Biochim Pol 56 3 — Lin CH, Sheu GT, Lin YW et al A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A lung cancer cells.

Process Biochem 45 9 — Article CAS Google Scholar. Zhang G, Sun J, Wang H et al a First isolation and characterization of a novel lectin with potent antitumor activity from a Russula mushroom. Phytomedicine 17 10 — Wong JH, Wang HX, Ng TB Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.

Appl Microbiol Biotechnol 81 4 — Wang HX, Ng TB a Purification of a laccase from fruiting bodies of the mushroom Pleurotus eryngii. Appl Microbiol Biotechnol 69 5 — El Fakharany EM, Haroun BM, Ng TB et al Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells.

Article PubMed Google Scholar. Zhang GQ, Wang YF, Zhang XQ b Purification and characterization of a novel laccase from the edible mushroom Clitocybe maxima.

Process Biochem 45 5 — Ko JL, Hsu CT, Lin RH et al A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence.

Eur J Biochem — Lin WH, Huang CH, Hsu CI et al Dimerization of the N-terminal amphipathic a-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae Fip-gts defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem — Hsu HC, Hsu CI, Lin RH et al Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea.

Biochem J — Du M, Zhao L, Li CR Purification and characterization of a novel fungi Se-containing protein from Se-enriched Ganoderma lucidum mushroom and its Se-dependent radical scavenging activity. Eur Food Res Technol 5 — Chen JN, Wang YT, Wu JS A glycoprotein extracted from golden oyster mushroom Pleurotus citrinopileatus exhibiting growth inhibitory effect against U leukemia cells.

J Agric Food Chem 57 15 — Kodama N, Komuta K, Nanba H Can maitake MD fraction aid cancer patients? Altern Med Rev — Cote J, Caillet S, Doyon G Bioactive compounds in cranberries and their biological properties.

Crit Rev Food Sci Nutr 50 7 — Int J Mol Sci — Dziezak JD Antioxidants-the ultimate answer to oxidation. Food Technol 40 9 Yagi K A rapid method for evaluation of oxidation and antioxidants.

Agric Biol Chem 34 1 — Palacios I, Lozano M, Moro C Antioxidant properties of phenolic compounds occurring in edible mushrooms. Food Chem 3 — Dugler B, Gonuz A, Gucin F Antimicrobial activity of the macrofungus Cantharellus cibarius.

JBS 7 9 — Witkowska MA, Zujko ME, Mironczuk-Chodakowska I Comparative study of wild edible mushrooms as sources of antioxidants.

Int J Med Mushrooms 13 4 — Nukata M, Hashimoto T, Yamamoto I et al Neogrifolin derivatives possessing anti-oxidative activity from the mushroom Albatrellus ovinus. Phytochemistry 59 7 — Mizuno T Bioactive substances in Hericium erinaceus Bull. Yamabushitake , and its medicinal utilization.

Attarat J, Phermthai T Bioactive compounds in three edible Lentinus mushrooms. Walailak J Sci Technol 12 6 — Chowdhury MMH, Kubra K, Ahmed SR Screening of antimicrobial, antioxidant properties and bioactive compounds of some edible mushrooms cultivated in Bangladesh.

Ann Clin Microbiol Antimicrob Dai YC, Zhou LW, Cui BK et al Current advances in Phellinus sensu lato: medicinal species, functions, metabolites and mechanisms. Appl Microbiol Biotechnol 87 5 — Elsayed EA, Enshasy HE, Wadaan MAM et al Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications.

Mediat Inflamm — Badalyan SM Potential of mushroom bioactive molecules to develop healthcare biotech products. In: Proceedings of the 8th international conference on mushroom biology and mushroom products ICMBMP8.

Wu DM, Duan WQ, Liu Y, Cen Y Anti-inflammatory effect of the polysaccharides of Golden needle mushroom in burned rats. Int J Biol Macromol 46 1 — Batbayar S, Lee DH, Kim HW Immunomodulation of fungal b-glucan in host defense signaling by dectin Biomol Ther 20 5 — Lavi I, Levinson D, Peri I et al Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from Pleurotus pulmonarius mycelium and fruiting bodies.

Appl Microbiol Biotechnol 85 6 — Firenzuoli F, Gori L, Lombardo G The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems.

Evid Based Complement Altern Med 5 1 :3— Carbohydr Res 2 — Lavi I, Nimri L, Levinson D et al Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice. Karst LingZhi, Reishi mushroom extract in patients with chronic hepatitis B.

Int J Med Mushrooms 4 4 — Tong H, Xia F, Feng K et al Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus. Bioresour Technol — Chatterjee S, Biswas G, Basu SK Antineoplastic effect of mushrooms: a review.

Aust J Crop Sci 5 7 — Kim GY, Kim SH, Hwang SY et al Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice.

Biol Pharm Bull — Morigiwa A, Kitabatake K, Fujimoto Y et al Angiotensin converting enzyme inhibitory triterpenes from Ganoderma lucidum.

Ma L, Chen H, Dong P et al Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus. Food Chem 1—4 — Han J, Chen Y, Bao L Anti-inflammatory and cytotoxic cyathane diterpenoids from the medicinal fungus Cyathus africanus. Fitoterapia — Chen CC, Shiao YJ, Lin RD et al Neuroprotective diterpenes from the fruiting body of Antrodia camphorata.

Khan MA et al Hericium erinaceus : an edible mushroom with medicinal values. J Complement Integr Med Standish LJ et al Trametes versicolor mushroom immune therapy in breast cancer.

J Soc Integr Oncol — Badalyan SM The main groups of therapeutic compounds of medicinal mushrooms. Probl Med Mycol — De Baets S, Vandamme EJ Extracellular Tremella polysaccharides: structure, properties and applications. Biotechnol Lett — Consulta Detalhada ×. Email ×.

Seu nome Seu email Enviar para. Exportar ×. Formato de exportação: RIS Reference Manager, ProCite, EndNote, etc CSV Excel, etc Citação. RSS ×. Visualizar RSS Adicionar RSS na Minha BVS. Imprimir ×. Esta página Referências selecionadas 0.

Frontiers | Mushrooms as Potential Sources of Active Metabolites and Medicines Draft genome of Omphalotus olearius provides a predictive framework for sesquiterpenoid natural product biosynthesis in Basidiomycota. Ectopic expression of the chemokine CXCL17 in colon cancer cells. Structural analysis of water-soluble polysaccharides in the fruiting body of Dictyophora indusiata and their in vivo antioxidant activities. Rea, k Rigidoporus sp. De novo sequencing and analysis of the termite mushroom Termitomyces albuminosus transcriptome to discover putative genes involved in bioactive component biosynthesis. Effects of Ganoderma lucidum Curtis P.
Mushroom Bioactive Compounds Conteúdo principal Bioative Busca 2 Rodapé 3. Home Pesquisa Bioactive compounds from mushrooms: An emerging bioresources of Liver Health Strategies and nutraceuticals Vegan lunch ideas compounds Biocative mushrooms: Mushrlom Vegan lunch ideas bioresources Conpounds food and nutraceuticals. Kour, Harpreet, Kour, Divjot, Kour, Satvinder, Singh, Shaveta, Jawad Hashmi, Syed Azhar, Yadav, Ajar Nath, Kumar, Krishan, Sharma, Yash Pal, Ahluwalia, Amrik Singh. Food Bioscience ; : Artigo em Inglês ScienceDirect ID: covidwho Anti cancer compounds ; Bioactive compounds ; Biodiversity ; Food industry ; Mushrooms ; Nutraceuticals ; Nutritive value. Texto completo.

Author: Shaktilkree

2 thoughts on “Mushroom Bioactive Compounds

  1. Sie lassen den Fehler zu. Ich kann die Position verteidigen. Schreiben Sie mir in PM, wir werden besprechen.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com